Prestige Wealth Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $45.7K | Sell |
87
-3
| -3% | -$1.58K | 0.01% | 263 |
|
2025
Q1 | $57.1K | Sell |
90
-11
| -11% | -$6.98K | 0.01% | 235 |
|
2024
Q4 | $71.9K | Buy |
101
+19
| +23% | +$13.5K | 0.02% | 225 |
|
2024
Q3 | $86.2K | Sell |
82
-20
| -20% | -$21K | 0.02% | 204 |
|
2024
Q2 | $107K | Sell |
102
-49
| -32% | -$51.5K | 0.02% | 172 |
|
2024
Q1 | $145K | Sell |
151
-16
| -10% | -$15.4K | 0.03% | 172 |
|
2023
Q4 | $147K | Sell |
167
-5
| -3% | -$4.39K | 0.03% | 154 |
|
2023
Q3 | $142K | Buy |
172
+3
| +2% | +$2.47K | 0.03% | 156 |
|
2023
Q2 | $121K | Sell |
169
-292
| -63% | -$210K | 0.03% | 187 |
|
2023
Q1 | $379K | Buy |
461
+293
| +174% | +$241K | 0.1% | 100 |
|
2022
Q4 | $121K | Sell |
168
-11
| -6% | -$7.94K | 0.03% | 172 |
|
2022
Q3 | $124K | Sell |
179
-2
| -1% | -$1.39K | 0.03% | 159 |
|
2022
Q2 | $107K | Buy |
181
+6
| +3% | +$3.55K | 0.03% | 171 |
|
2022
Q1 | $122K | Sell |
175
-293
| -63% | -$204K | 0.03% | 173 |
|
2021
Q4 | $295K | Buy |
468
+118
| +34% | +$74.4K | 0.07% | 113 |
|
2021
Q3 | $212K | Buy |
350
+219
| +167% | +$133K | 0.05% | 132 |
|
2021
Q2 | $73K | Sell |
131
-4
| -3% | -$2.23K | 0.02% | 207 |
|
2021
Q1 | $64K | Buy |
135
+42
| +45% | +$19.9K | 0.02% | 225 |
|
2020
Q4 | $45K | Sell |
93
-88
| -49% | -$42.6K | 0.01% | 259 |
|
2020
Q3 | $101K | Buy |
181
+32
| +21% | +$17.9K | 0.03% | 173 |
|
2020
Q2 | $93K | Buy |
149
+99
| +198% | +$61.8K | 0.03% | 159 |
|
2020
Q1 | $24K | Hold |
50
| – | – | 0.01% | 256 |
|
2019
Q4 | $19K | Hold |
50
| – | – | 0.01% | 299 |
|
2019
Q3 | $14K | Hold |
50
| – | – | 0.01% | 313 |
|
2019
Q2 | $16K | Hold |
50
| – | – | 0.01% | 293 |
|
2019
Q1 | $21K | Sell |
50
-34
| -40% | -$14.3K | 0.01% | 274 |
|
2018
Q4 | $31K | Buy |
+84
| New | +$31K | 0.02% | 246 |
|